Related Experiment Video

Updated: Jul 13, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

By the way, doctor. Must I take aspirin?

Nancy Keating

    Harvard Health Letter
    |August 1, 2007
    PubMed

    Insights

    This patient has ulcerative colitis and diabetes, facing conflicting medical advice on aspirin therapy. One doctor advocates for aspirin to prevent heart attacks and strokes, while another suggests using it only if benefits arise, to avoid colitis complications.

    Area of Science:

    • Gastroenterology
    • Cardiology
    • Internal Medicine

    Background:

    • A 56-year-old woman with a 20-year history of ulcerative colitis and diabetes presents a complex clinical scenario.
    • She is experiencing conflicting medical advice regarding the initiation of aspirin therapy.

    Purpose of the Study:

    • To explore the potential benefits and risks of aspirin therapy in patients with ulcerative colitis and diabetes.
    • To reconcile differing medical opinions on proactive versus reactive aspirin use in this patient population.

    Main Methods:

    • This is a case study review and clinical decision-making analysis.
    • Consultation with gastroenterology and general medicine specialists was performed.

    Main Results:

    • One physician recommends aspirin for primary prevention of cardiovascular events (heart attack, stroke), citing mortality rates.
    • The patient's long-term gastroenterologist advises a cautious approach, reserving aspirin for situations with clear indications to prevent exacerbating ulcerative colitis.

    Conclusions:

    • The optimal management strategy for aspirin therapy in patients with comorbid ulcerative colitis and diabetes requires careful individualized assessment.
    • Balancing the risks of cardiovascular events against the potential for gastrointestinal complications, specifically colitis flares, is crucial.

    More Related Videos

    The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

    The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

    Published on: February 28, 2012

    Related Concept Videos

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

    Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
    Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

    Anticoagulant Drugs: Low-Molecular-Weight Heparins

    Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
    Drug toxicity: Drug–Drug Interaction01:30

    Drug toxicity: Drug–Drug Interaction

    Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
    Pre-Procedural Guidelines for Assessing Blood Pressure01:10

    Pre-Procedural Guidelines for Assessing Blood Pressure

    Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.